After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

IntegraCLIM submitted under EDCTP3 call on climate and infectious diseases in sub-Saharan Africa

IntegraCLIM is a research and implementation initiative aimed at evaluating the cost-effectiveness and operational feasibility of an integrated climate-adaptive intervention package designed to reduce climate-sensitive infectious diseases in sub-Saharan Africa. 

Read More

African-European Symposium: Challenges in Research Ethics Assessment, 13:00 – 18:00 CET, May 25th, 2021.

The symposium,  organised by The Embassy of Good Science, in collaboration with EUREC, BERC-Luso, AfriEthique, and LiberHetica, aims to facilitate the sharing of experiences and perspectives on research ethics assessment challenges between African and

Read More

PREPARE: Strengthening Regulatory, Ethics, and Pharmacovigilance Systems for Health Preparedness in Sub-Saharan Africa

PREPARE – Pharmacovigilance, Regulatory and Ethics Preparedness and Response Innovation Network – is one of the newest proposal that we submitted to the European Commission under the Global Health EDCTP3 programme.

Read More